The first month of 2017 is not only the beginning of the new year, it is also the world's most powerful country - the United States, has a new president of the beginning, which also represents the United States is about to start the past eight years the Obama administration Policy change. Well-known medical media MobiHealthNews and some experts to discuss, while their ideas and some of my own ideas combined here, where we together for the next year's health development in the field made some of the following predictions.

Trump's election to the president will reduce the use of IT in the medical field

While most of the things that are now related to President Donald Trump are still uncertain, Chilmark founder and co-managing partner John Moore argue that this uncertainty itself will lead to a lot of people in some large Health care IT project unemployed or at least forced to rest for some time.
"It is because of this hesitation (for example, about the fact that ACA will be abolished), and I believe that health care and health care executives need to take a very cautious approach in their future work, so I think Many of the big start-up companies in the healthcare IT market will be weaker in 2017. But if they have already signed the contract, it will be a process or process involving a wide range of EHR replacement, although some projects may still continue, but I That some of the more projects may be shelved, and then whether to continue in the future will depend on what will happen in the future.

John Moore believes that today's value-based health care is a trend, regardless of Donald Trump future what kind of policy guidance, this trend will continue. However, it is worth our attention that the loss of funds in the area of health insurance may slow down the development of this value-based business model throughout the healthcare industry.

NIH is responsible for funding the precision medical program and tackling the cancer program can take any way. It is reported that Trump and Vice President McDowsey have the incentive to support these projects, but at the same time Trump needs to cut spending, so all his planned work and scientific spending are still in a state of instability. Dr. Eric Topol, who led the Scripps Institute for Transformation Studies, received a $ 200 million grant from PMI, who told the Buzzfeed shortly after the election that he was "very worried" about the results of the election, NIH's investment and biomedical research fund "can almost certainly be declared risky."

We can see the M & A and IPO market boom

Federer's co-founder Fred Wilson wrote on his blog that Trump's tax plan could lead to a new cash flow accident, but could also translate into a boom in the healthcare sector. In the area of digital health care, there has been an increasing number of mergers and acquisitions in the past few years, and the flow of funds in this process continues to be so strong that, in the next 2017, when we see more and more The flow of funds and more and more frequent cases of mergers and acquisitions, do not be too surprised to show.
In addition, Snapchat predicted that 2017 may also lead to the upsurge of technology IPO, some digital medical companies may be involved in this boom. As for what companies can have the opportunity to go public next year, I want to leave this question to you. If you feel the right answer, let me know by email or SMS, you can express your forecast on Twitter and other social networking sites, about which companies can succeed in the next year.

Pharmaceutical companies' investment in digital health will grow slowly and steadily

Each year, pharmaceutical companies invest in digital health for larger and larger investments, such as Epson's smart syringes, or more consumer-oriented applications from AstraZeneca and Novartis, Johnson & Johnson and Roche will continue to invest in mobile devices to manage diabetes with reasonable and effective management. At the same time, we have reason to believe that this trend should not continue until 2017.
Moore said the pharmaceutical industry is slowly growing, although it is a few years ago to slowly approached people's attention, but now they have really entered the digital health care space.
"If you push 5 years ago, you will find the pharmaceutical industry is very depressed and heavy, because the pharmaceutical factory price of drugs to develop more and more high," he said. "Today, pharmaceutical companies have been able to effectively and formally collect the true response of each patient to the drug, and then to pricing it because if the study clearly shows good results of treatment, then there will be some pricing bonuses and suggested using them Of the drug. "